Article is a month+ old and there is nothing new beside the great update about Sabby and others funds.for the first time ever KTOV has real insiders ( about 50% ownership) and be sure they did tbey DD or potential before invested $12m. Cap is only $22m a/o today so close to NDA submission for a drug that could easily bring in few hundred million in revenue annually. Backup w/patent till 2029. A very solid balance sheet, zero debt and trading close to Cash on Hand.
News 
Market Data 
Discover 
AI
